发明名称 |
COMPOSITIONS AND METHODS OF TREATING PULMONARY HYPERTENSION |
摘要 |
Provided are formulations comprising therapeutically effective amounts of ambrisentan or a pharmaceutically acceptable salt thereof and tadalafil or a pharmaceutically acceptable salt thereof and methods of treating and/or preventing pulmonary hypertension by administration of the formulations. |
申请公布号 |
US2014275098(A1) |
申请公布日期 |
2014.09.18 |
申请号 |
US201314079548 |
申请日期 |
2013.11.13 |
申请人 |
Belardinelli Luiz;Gillies Hunter Campbell;Liang Faquan;Shryock John;Yang Suya |
发明人 |
Belardinelli Luiz;Gillies Hunter Campbell;Liang Faquan;Shryock John;Yang Suya |
分类号 |
A61K31/505;A61K45/06;A61K31/4985 |
主分类号 |
A61K31/505 |
代理机构 |
|
代理人 |
|
主权项 |
1. A combination therapy comprising:
a therapeutically effective amount of a selective type-A endothelin receptor antagonist (ERA) selected from the group consisting of ambrisentan, sitaxsentan and pharmaceutically acceptable salts thereof, and a therapeutically effective amount of a phosphodiesterase type 5 (PDE5) inhibitor selected from the group consisting of sildenafil, tadalafil, vardenafil and pharmaceutically acceptable salts thereof, wherein the weight ratio of the selective type-A ERA and the PDE5 inhibitor is in a range from about 1:1 to about 1:10. |
地址 |
Palo Alto CA US |